LobbyingEssilorluxottica USA lobbying by quarter
Essilorluxottica USA's latest lobbying report covers Q2 2026, at $180K. The four quarters Q4 2025–Q3 2026 total $480K. Its first report covers Q2 2024; the issues it reports most are Health Issues.
Essilorluxottica USA
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $480K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2024 | $150K | 1 |
| Q3 2024 | $130K | 1 |
| Q4 2024 | $130K | 1 |
| Q1 2025 | $130K | 1 |
| Q2 2025 | $150K | 1 |
| Q3 2025 | $130K | 1 |
| Q4 2025 | $150K | 1 |
| Q1 2026 | $150K | 1 |
| Q2 2026 | $180K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$1.3M · 9 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES9 reports
- SENATE9 reports
- Homeland Security, Dept of (DHS)2 reports
- Intl Trade Administration (ITA)2 reports
- Government Accountability Office (GAO)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseEssilorluxottica USA | $1.3M | 9 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 09/14for Q3 | Miller Strategies | Under $5,000 |
| 07/10for Q2 | In-house | $180K |
| 04/08for Q1 | In-house | $150K |
| 01/05for Q4 2025 | In-house | $150K |
| 25/10/08for Q3 2025 | In-house | $130K |
| 25/07/08for Q2 2025 | In-house | $150K |
| 25/04/11for Q1 2025 | In-house | $130K |
| 25/01/03for Q4 2024 | In-house | $130K |
| 24/10/09for Q3 2024 | In-house | $130K |
| 24/07/11for Q2 2024 | In-house | $150K |
| 24/05/09for Q2 2024 | In-house | Under $5,000 |